Molecular signatures of inherited and acquired sporadic late onset

Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after initial investigations. We sought to identify biomarkers facilitating this distinction and to investigate the pathophysiology of nemaline rod formation in these different disorders. Twenty-two muscle samples from patients affected by SLONM or iNM underwent quantitative histological analysis, laser capture microdissection for proteomic analysis of nemaline rod areas and rod-free areas, and transcriptomic analysis. In all iNM samples, nemaline rods were found in subsarcolemmal or central aggregates, whereas they were diffusely distributed within muscle fibers in most SLONM samples. In SLONM, muscle fibers harboring nemaline rods were smaller than those without rods. Necrotic fibers, increased endomysial connective tissue, and atrophic fibers filled with nemaline rods were more common in SLONM. Proteomic analysis detected differentially expressed proteins between nemaline rod areas and rod-free areas, as well as between SLONM and iNM. These differentially expressed proteins implicated immune, structural, metabolic, and cellular processes in disease pathophysiology. Notably, immunoglobulin overexpression with accumulation in nemaline rod areas was detected in SLONM. Transcriptomic analysis corroborated proteomic findings and further revealed substantial gene expression differences between SLONM and iNM. Overall, we identified unique pathological and molecular signatures associated with SLONM and iNM, suggesting distinct underlying pathophysiological mechanisms. These findings represent a step towards enhanced diagnostic tools and towards development of treatments for SLONM.

Erratum to Genetic and molecular changes in ovarian cancer

Human SOX17 Antibody AF1924: R&D Systems

miRNA biogenesis and inherited disorders: clinico-molecular

Single-Cell Transcriptomics Reveals a Conserved Metaplasia Program

Molecular signatures of inherited and acquired sporadic late onset

Disruption of Fgf13 Causes Synaptic Excitatory–Inhibitory

Molecular signatures of inherited and acquired sporadic late onset

Bone marrow-derived inducible microglia-like cells ameliorate

Clonal Expansion in Cardiovascular Pathology

Precision medicine in complex diseases—Molecular subgrouping for

Frontotemporal Dementia and Frontotemporal Lobar Degeneration

Sarcoma treatment in the era of molecular medicine

Loop Stefan Nicolau

Sporadic Late-Onset Nemaline Myopathy: Current Landscape

Molecular profiling in breast cancer